News in brief:ALZHEIMER'S DISEASE

NICE is to face a judicial review over its ruling that people newly diagnosed with early stage AlzheimerÕs disease should be denied drug treatment. Drug manufacturers Eisai and Pfizer are the main claimants but the AlzheimerÕs Society has been granted permission to act as an interested party. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us: